Improving pregnancy outcomes in patients with recurrent implantation failure: The power of RNA-seq-based endometrial receptivity testing

Jie Li,Yan Liu,Lin Li,Weijun Chen,Dujuan Xu,Aimei Xiao,Ling Ma,Wanxue Jiang,Lijuan Yang
DOI: https://doi.org/10.1097/md.0000000000040210
IF: 1.6
2024-10-30
Medicine
Abstract:Assisted reproductive technology (ART) offers individuals experiencing infertility the prospect of achieving pregnancy. [ 1 ] Nonetheless, approximately 15% of patients experience recurrent implantation failure (RIF) following in vitro fertilization and embryo transfer (IVF-ET). [ 2 ] RIF is defined as the failure to achieve an intrauterine gestational sac after 2 or more ET cycles. [ 3 ] To address RIF, embryologists have utilized advanced technologies such as time-lapse embryo culture technology (TLT) and preimplantation genetic testing (PGT) to select the most viable embryos for transfer. Moreover, clinicians have designed personalized treatment strategies to counteract other RIF contributing factors, such as immunological disturbances, thrombophilia, and hormonal or metabolic disorders. Despite these efforts, unexplained recurrent implantation failure (uRIF) remains a significant challenge for both patients and physicians due to its unknown etiology.
medicine, general & internal
What problem does this paper attempt to address?